Viemed Healthcare Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio27.7229.5046.2022.669.63
Forward P/E19.3221.2234.3618.8933.26
P/S Ratio1.391.652.071.772.31
P/B Ratio2.342.652.962.183.72
Price/Tangible Book3.203.622.962.183.72
Price/FCF236.9315.8059.2675.1613.77
Price/OCF7.996.6810.369.198.65
Enterprise Value Ratios
EV/Revenue1.381.661.951.602.17
EV/EBITDA7.288.1111.278.609.34
EV/EBIT17.9719.5332.2417.8313.61
EV/FCF235.2215.8555.8268.2412.92
Profitability & Returns
Return on Equity (ROE)0.09%0.10%0.06%0.10%0.50%
Return on Assets (ROA)0.06%0.07%0.04%0.06%0.13%
Return on Invested Capital (ROIC)0.10%0.11%0.08%0.11%0.37%
Return on Capital Employed (ROCE)0.12%0.13%0.09%0.10%0.23%
Leverage & Solvency Ratios
Debt/Equity0.050.090.010.070.14
Debt/EBITDA0.160.270.030.300.37
Debt/FCF5.210.540.142.440.52
Liquidity Ratios
Current Ratio1.421.192.112.662.05
Quick Ratio1.140.971.712.421.88
Efficiency Ratios
Asset Turnover1.351.351.181.021.35
Inventory Turnover20.3517.1217.9618.3127.90
Yield & Distribution Ratios
Earnings Yield0.04%0.03%0.02%0.04%0.10%
FCF Yield0.00%0.06%0.02%0.01%0.07%
Buyback Yield-0.01%-0.01%0.02%0.00%-0.02%